Kj. Kennedy et al., A disubstituted NAD(+) analogue is a nanomolar inhibitor of trypanosomal glyceraldehyde-3-phosphate dehydrogenase, BIOORG MED, 11(2), 2001, pp. 95-98
N-6-Naphthalenemethyl-2'-methoxybenzamido-beta -NAD(+), a derivative of a l
ow micromolar first-generation inhibitor of trypanosomal glyceraldehyde pho
sphate dehydrogenase (GAPDH), was synthesized, taking advantage of methodol
ogy for the selective phosphitylation of nucleosides. The compound was foun
d to be a poor alternate cosubstrate for GAPDH, but an extremely potent inh
ibitor. Although intended for use in crystallization trials, the analogue p
resents possibilities for further drug design. (C) 2001 Elsevier Science Lt
d. All rights reserved.